These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 35126146

  • 1. Tumor Necrosis Factor Alpha -308G/A Gene Polymorphisms Combined with Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio Predicts the Efficacy and Safety of Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis Arthritis.
    Wang Z, Kong L, Zhang H, Sun F, Guo Z, Zhang R, Dou Y.
    Front Pharmacol; 2021; 12():811719. PubMed ID: 35126146
    [Abstract] [Full Text] [Related]

  • 2. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-α agents in patients with rheumatoid arthritis: a retrospective chart review analysis.
    Lee HN, Kim YK, Kim GT, Ahn E, So MW, Sohn DH, Lee SG.
    Rheumatol Int; 2019 May; 39(5):859-868. PubMed ID: 30874873
    [Abstract] [Full Text] [Related]

  • 3. IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients.
    Iwaszko M, Wielińska J, Świerkot J, Kolossa K, Sokolik R, Bugaj B, Chaszczewska-Markowska M, Jeka S, Bogunia-Kubik K.
    Front Immunol; 2021 May; 12():631603. PubMed ID: 34177886
    [Abstract] [Full Text] [Related]

  • 4. Neutrophil-lymphocyte and platelet-lymphocyte rate and their seasonal differences in ankylosing spondylitis and rheumatoid arthritis patients using anti-TNF medication.
    Enginar AU, Kacar C.
    Bratisl Lek Listy; 2019 May; 120(8):586-592. PubMed ID: 31379182
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis.
    Kim DS, Shin D, Lee MS, Kim HJ, Kim DY, Kim SM, Lee MG.
    J Dermatol; 2016 Mar; 43(3):305-10. PubMed ID: 26381893
    [Abstract] [Full Text] [Related]

  • 8. Neutrophil/lymphocyte and platelet/lymphocyte ratios as potential markers of disease activity in patients with Ankylosing spondylitis: a case-control study.
    Al-Osami MH, Awadh NI, Khalid KB, Awadh AI.
    Adv Rheumatol; 2020 Jan 29; 60(1):13. PubMed ID: 32000859
    [Abstract] [Full Text] [Related]

  • 9. Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in patients with rheumatoid arthritis.
    Peng YF, Cao L, Zeng YH, Zhang ZX, Chen D, Zhang Q, Zhu YS.
    Open Med (Wars); 2015 Jan 29; 10(1):249-253. PubMed ID: 28352702
    [Abstract] [Full Text] [Related]

  • 10. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.
    Uslu AU, Küçük A, Şahin A, Ugan Y, Yılmaz R, Güngör T, Bağcacı S, Küçükşen S.
    Int J Rheum Dis; 2015 Sep 29; 18(7):731-5. PubMed ID: 25900081
    [Abstract] [Full Text] [Related]

  • 11. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics.
    Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K, Nakagawa H.
    J Dermatol; 2017 Oct 29; 44(10):1112-1121. PubMed ID: 28493493
    [Abstract] [Full Text] [Related]

  • 12. Association of single nucleotide polymorphism at position -308 of the tumor necrosis factor-alpha gene with ankylosing spondylitis and rheumatoid arthritis.
    Manolova I, Ivanova M, Stoilov R, Rashkov R, Stanilova S.
    Biotechnol Biotechnol Equip; 2014 Nov 02; 28(6):1108-1114. PubMed ID: 26019597
    [Abstract] [Full Text] [Related]

  • 13. Comparison of Platelets-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Rheumatoid Arthritis and Ankylosing Spondylitis.
    Khan S, Yousaf MJ, Rashid A, Manzar A.
    J Coll Physicians Surg Pak; 2024 Jan 02; 34(1):68-72. PubMed ID: 38185964
    [Abstract] [Full Text] [Related]

  • 14. Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab.
    Sargin G, Senturk T, Yavasoglu I, Kose R.
    Int J Rheum Dis; 2018 Dec 02; 21(12):2122-2127. PubMed ID: 30338636
    [Abstract] [Full Text] [Related]

  • 15. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
    Morales-Lara MJ, Cañete JD, Torres-Moreno D, Hernández MV, Pedrero F, Celis R, García-Simón MS, Conesa-Zamora P.
    Joint Bone Spine; 2012 Dec 02; 79(6):591-6. PubMed ID: 22480748
    [Abstract] [Full Text] [Related]

  • 16. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis.
    Erre GL, Paliogiannis P, Castagna F, Mangoni AA, Carru C, Passiu G, Zinellu A.
    Eur J Clin Invest; 2019 Jan 02; 49(1):e13037. PubMed ID: 30316204
    [Abstract] [Full Text] [Related]

  • 17. Role of Platelet/Lymphocyte, Neutrophil/Lymphocyte, and Interleukin-37/Interleukin-17 Ratios in the Occurrence and Treatment of Rheumatoid Arthritis.
    Meng Y, Cai XL, Cong S, Sun J, Hu YW, Gu YQ, Ma XM, Luo L.
    Immunol Invest; 2024 Apr 02; 53(3):464-474. PubMed ID: 38477623
    [Abstract] [Full Text] [Related]

  • 18. Platelet/Lymphocyte, Lymphocyte/Monocyte, and Neutrophil/Lymphocyte Ratios as Biomarkers in Patients with Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Chen Q, Chen DY, Xu XZ, Liu YY, Yin TT, Li D.
    Med Sci Monit; 2019 Aug 29; 25():6474-6481. PubMed ID: 31462627
    [Abstract] [Full Text] [Related]

  • 19. The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients.
    Seitz M, Wirthmüller U, Möller B, Villiger PM.
    Rheumatology (Oxford); 2007 Jan 29; 46(1):93-6. PubMed ID: 16720636
    [Abstract] [Full Text] [Related]

  • 20. High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis.
    Moon DH, Kim A, Song BW, Kim YK, Kim GT, Ahn EY, So MW, Lee SG.
    Pharmaceuticals (Basel); 2023 Mar 01; 16(3):. PubMed ID: 36986479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.